These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 23222419)

  • 21. Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort.
    McKenzie KA; El Ters M; Torres VE; Harris PC; Chapman AB; Mrug M; Rahbari-Oskoui FF; Bae KT; Landsittel DP; Bennett WM; Yu ASL; Mahnken JD
    BMC Nephrol; 2018 Dec; 19(1):378. PubMed ID: 30591038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid high-performance semi-automated tool to measure total kidney volume from MRI in autosomal dominant polycystic kidney disease.
    Simms RJ; Doshi T; Metherall P; Ryan D; Wright P; Gruel N; van Gastel MDA; Gansevoort RT; Tindale W; Ong ACM
    Eur Radiol; 2019 Aug; 29(8):4188-4197. PubMed ID: 30666443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low birth weight is associated with earlier onset of end-stage renal disease in Danish patients with autosomal dominant polycystic kidney disease.
    Orskov B; Christensen KB; Feldt-Rasmussen B; Strandgaard S
    Kidney Int; 2012 May; 81(9):919-24. PubMed ID: 22297678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of urinary supersaturations for lithogenic salts in the progression of autosomal dominant polycystic kidney disease.
    Ferraro PM; Bargagli M; Faller N; Anderegg MA; Huynh-Do U; Vogt B; Gambaro G; Fuster DG
    J Nephrol; 2023 May; 36(4):1011-1018. PubMed ID: 36528688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease.
    Han M; Park HC; Kim H; Jo HA; Huh H; Jang JY; Kang AY; Kim SH; Cheong HI; Kang DH; Yang J; Oh KH; Hwang YH; Ahn C
    BMC Nephrol; 2014 Apr; 15():63. PubMed ID: 24739095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance imaging of kidney and cyst volume in children with ADPKD.
    Cadnapaphornchai MA; Masoumi A; Strain JD; McFann K; Schrier RW
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):369-76. PubMed ID: 21115621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum uric acid levels and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease.
    Kocyigit I; Yilmaz MI; Orscelik O; Sipahioglu MH; Unal A; Eroglu E; Kalay N; Tokgoz B; Axelsson J; Oymak O
    Nephron Clin Pract; 2013; 123(3-4):157-64. PubMed ID: 23887359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model.
    McEwan P; Bennett Wilton H; Ong ACM; Ørskov B; Sandford R; Scolari F; Cabrera MV; Walz G; O'Reilly K; Robinson P
    BMC Nephrol; 2018 Feb; 19(1):37. PubMed ID: 29439650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in age at ESRD in autosomal dominant polycystic kidney disease.
    Reed BY; McFann K; Bekheirnia MR; Nobakhthaghighi N; Masoumi A; Johnson AM; Shamshirsaz AA; Kelleher CL; Schrier RW
    Am J Kidney Dis; 2008 Feb; 51(2):173-83. PubMed ID: 18215695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uric acid handling in autosomal dominant polycystic kidney disease with normal filtration rates.
    Kaehny WD; Tangel DJ; Johnson AM; Kimberling WJ; Schrier RW; Gabow PA
    Am J Med; 1990 Jul; 89(1):49-52. PubMed ID: 2368793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality risk in patients with autosomal dominant polycystic kidney disease.
    Mladsi D; Zhou X; Mader G; Sanon M; Wang J; Barnett C; Willey C; Seliger S
    BMC Nephrol; 2024 Feb; 25(1):56. PubMed ID: 38365638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.
    Cornec-Le Gall E; Audrézet MP; Rousseau A; Hourmant M; Renaudineau E; Charasse C; Morin MP; Moal MC; Dantal J; Wehbe B; Perrichot R; Frouget T; Vigneau C; Potier J; Jousset P; Guillodo MP; Siohan P; Terki N; Sawadogo T; Legrand D; Menoyo-Calonge V; Benarbia S; Besnier D; Longuet H; Férec C; Le Meur Y
    J Am Soc Nephrol; 2016 Mar; 27(3):942-51. PubMed ID: 26150605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
    Messchendorp AL; Meijer E; Visser FW; Engels GE; Kappert P; Losekoot M; Peters DJM; Gansevoort RT;
    Am J Nephrol; 2019; 50(5):375-385. PubMed ID: 31600749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α-lipoic acid in patients with autosomal dominant polycystic kidney disease.
    Lai S; Petramala L; Muscaritoli M; Cianci R; Mazzaferro S; Mitterhofer AP; Pasquali M; D'Ambrosio V; Carta M; Ansuini M; Ramaccini C; Galani A; Amabile MI; Molfino A; Letizia C
    Nutrition; 2020 Mar; 71():110594. PubMed ID: 31790890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?
    Higashihara E; Nutahara K; Tanbo M; Hara H; Miyazaki I; Kobayashi K; Nitatori T
    Nephrol Dial Transplant; 2014 Sep; 29(9):1710-9. PubMed ID: 24739484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensinogen and angiotensin II type 1 receptor gene polymorphism in patients with autosomal dominant polycystic kidney disease: effect on hypertension and ESRD.
    Lee KB; Kim UK
    Yonsei Med J; 2003 Aug; 44(4):641-7. PubMed ID: 12950120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation.
    de Mattos AM; Olyaei AJ; Prather JC; Golconda MS; Barry JM; Norman DJ
    Kidney Int; 2005 Feb; 67(2):714-20. PubMed ID: 15673321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: HOW AND WHY SHOULD WE IDENTIFY THE PATIENTS "RAPIDLY PROGRESSING" TO END-STAGE RENAL DISEASE?].
    Bodson A; Meunier P; Krzesinski JM; Jouret F
    Rev Med Liege; 2016 Apr; 71(4):184-92. PubMed ID: 27295898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of serum galectin-3 level with renal volume and function in adult polycystic kidney disease.
    Ozkurt S; Dogan I; Ozcan O; Fidan N; Bozaci I; Yilmaz B; Bilgin M
    Int Urol Nephrol; 2019 Jul; 51(7):1191-1197. PubMed ID: 31012038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
    Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.